Progress report from the NIDA Addiction Research Center (Preclinical Laboratory), Lexington, Ky.
D000818:Animals; D001665:Binding Sites; D004285:Dogs; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D008875:Middle Aged; D009316:National Institutes of Health (U.S.); D009538:Nicotine; D009293:Opioid-Related Disorders / Q000378:metabolism; D009892:Opium; D010620:Phenazocine / Q000031:analogs & derivatives / Q000378:metabolism; D012453:Saimiri; D012646:Self Administration; D019966:Substance-Related Disorders; D014029:Tobacco Use Disorder / Q000209:etiology; D014481:United States
D009538:Nicotine; C012134:SK&F 10047; D009892:Opium; D010620:Phenazocine